Approval · Notice of Compliance 8657 · 2007
EXUBERA: Notice of Compliance 8657
Issued March 20, 2007
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8657
- Date
- March 20, 2007
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Antidiabetic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| EXUBERA | 02293277 | — |
| EXUBERA | 02293285 | — |
Medicinal ingredients
- HUMAN INSULIN (RECOMBINANT) 1.02 MG per BLD
- HUMAN INSULIN (RECOMBINANT) 3.06 MG per BLD